These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 25504629)

  • 21. A concise methodology for the stereoselective synthesis of O-glycosylated amino acid building blocks: complete 1H NMR assignments and their application in solid-phase glycopeptide synthesis.
    Satyanarayana J; Gururaja TL; Naganagowda GA; Ramasubbu N; Levine MJ
    J Pept Res; 1998 Sep; 52(3):165-79. PubMed ID: 9774229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New t-butyl based aspartate protecting groups preventing aspartimide formation in Fmoc SPPS.
    Behrendt R; Huber S; Martí R; White P
    J Pept Sci; 2015 Aug; 21(8):680-7. PubMed ID: 26077723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Asparagine coupling in Fmoc solid phase peptide synthesis.
    Gausepohl H; Kraft M; Frank RW
    Int J Pept Protein Res; 1989 Oct; 34(4):287-94. PubMed ID: 2599767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of alpha-methyl selenocysteine and its utilization as a glutathione peroxidase mimic.
    Wehrle RJ; Ste Marie EJ; Hondal RJ; Masterson DS
    J Pept Sci; 2019 Jun; 25(6):e3173. PubMed ID: 31074180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Handles for Fmoc solid-phase synthesis of protected peptides.
    Góngora-Benítez M; Tulla-Puche J; Albericio F
    ACS Comb Sci; 2013 May; 15(5):217-28. PubMed ID: 23573835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and application of a Sec2-containing oligopeptide for method evaluation purposes in selenium speciation.
    Dernovics M; Vass A; Németh A; Magyar A
    Talanta; 2012 Sep; 99():186-93. PubMed ID: 22967540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Straightforward entry to S-glycosylated fmoc-amino acids and their application to solid phase synthesis of glycopeptides and glycopeptidomimetics.
    Comegna D; de Paola I; Saviano M; Del Gatto A; Zaccaro L
    Org Lett; 2015 Feb; 17(3):640-3. PubMed ID: 25622618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fmoc/solid-phase synthesis of Tyr(P)-containing peptides through t-butyl phosphate protection.
    Perich JW; Reynolds EC
    Int J Pept Protein Res; 1991 Jun; 37(6):572-5. PubMed ID: 1717394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in Fmoc solid-phase peptide synthesis.
    Behrendt R; White P; Offer J
    J Pept Sci; 2016 Jan; 22(1):4-27. PubMed ID: 26785684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Solid-Phase Total Synthesis of Dehydrotryptophan-Bearing Cyclic Peptides Tunicyclin B, Sclerotide A, CDA3a, and CDA4a using a Protected β-Hydroxytryptophan Building Block.
    Diamandas M; Moreira R; Taylor SD
    Org Lett; 2021 Apr; 23(8):3048-3052. PubMed ID: 33769052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fmoc SPPS using Perloza beaded cellulose.
    Englebretsen DR; Harding DR
    Int J Pept Protein Res; 1994 Jun; 43(6):546-54. PubMed ID: 7928085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficient manual Fmoc solid-phase synthesis of the N-terminal segment of surfactant protein B (SP-B(1-25)).
    Ramli S; Gentle IR; Ross BP
    Protein Pept Lett; 2009; 16(7):810-4. PubMed ID: 19601911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of peptide amides by Fmoc-solid-phase peptide synthesis and acid labile anchor groups.
    Stüber W; Knolle J; Breipohl G
    Int J Pept Protein Res; 1989 Sep; 34(3):215-21. PubMed ID: 2599759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation, isolation, and characterization of Nalpha-Fmoc-peptide isocyanates: solution synthesis of oligo-alpha-peptidyl ureas.
    Sureshbabu VV; Patil BS; Venkataramanarao R
    J Org Chem; 2006 Sep; 71(20):7697-705. PubMed ID: 16995676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Automated Fmoc-based solid-phase synthesis of peptide thioesters with self-purification effect and application in the construction of immobilized SH3 domains.
    Mende F; Beisswenger M; Seitz O
    J Am Chem Soc; 2010 Aug; 132(32):11110-8. PubMed ID: 20662535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of acid-labile S-protecting groups to prevent Cys racemization in Fmoc solid-phase peptide synthesis.
    Hibino H; Miki Y; Nishiuchi Y
    J Pept Sci; 2014 Jan; 20(1):30-5. PubMed ID: 24357151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and application of Fmoc-His(3-Bum)-OH.
    Mergler M; Dick F; Sax B; Schwindling J; Vorherr TH
    J Pept Sci; 2001 Sep; 7(9):502-10. PubMed ID: 11587189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthetic procedure for N-Fmoc amino acyl-N-sulfanylethylaniline linker as crypto-peptide thioester precursor with application to native chemical ligation.
    Sakamoto K; Sato K; Shigenaga A; Tsuji K; Tsuda S; Hibino H; Nishiuchi Y; Otaka A
    J Org Chem; 2012 Aug; 77(16):6948-58. PubMed ID: 22816612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of selenopeptides: an alternative way of incorporating selenocystine.
    Aravindhan S; Singh HB; Zeller M; Butcher RJ
    Amino Acids; 2019 Apr; 51(4):661-667. PubMed ID: 30798465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A one-pot procedure for the preparation of N-9-fluorenylmethyloxycarbonyl-α-amino diazoketones from α-amino acids.
    Siciliano C; De Marco R; Guidi LE; Spinella M; Liguori A
    J Org Chem; 2012 Dec; 77(23):10575-82. PubMed ID: 23146162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.